BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 1737439)

  • 1. Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units.
    Pierson CL; Friedman BA
    Diagn Microbiol Infect Dis; 1992 Feb; 15(2 Suppl):19S-30S. PubMed ID: 1737439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).
    Rhomberg PR; Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):57-62. PubMed ID: 16631338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program.
    Mendes C; Hsiung A; Kiffer C; Oplustil C; Sinto S; Mimica I; Zoccoli C;
    Braz J Infect Dis; 2000 Oct; 4(5):236-44. PubMed ID: 11063555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance patterns among selective Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.
    Orrett FA
    Saudi Med J; 2004 Apr; 25(4):478-83. PubMed ID: 15083220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity and pharmacodynamics of commonly used antibiotics against adult systemic isolates of Escherichia coli and Pseudomonas aeruginosa at Forty US Hospitals.
    Eagye KJ; Kuti JL; Sutherland CA; Christensen H; Nicolau DP
    Clin Ther; 2009 Nov; 31(11):2678-88. PubMed ID: 20110010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focused microbiologic surveillance by specific hospital unit as a sensitive means of defining antimicrobial resistance problems.
    Stratton CW; Ratner H; Johnston PE; Schaffner W
    Diagn Microbiol Infect Dis; 1992 Feb; 15(2 Suppl):11S-18S. PubMed ID: 1737438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
    Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011).
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):443-8. PubMed ID: 24492025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of genetic determinants involved in beta-lactam- and multiresistance in a surgical ICU.
    van Loon HJ; Box AT; Verhoef J; Fluit AC
    Int J Antimicrob Agents; 2004 Aug; 24(2):130-4. PubMed ID: 15288311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
    Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
    Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal changes in bacterial resistance in German intensive care units, 2001-2003: data from the SARI (surveillance of antimicrobial use and antimicrobial resistance in intensive care units) project.
    Meyer E; Schwab F; Jonas D; Ruden H; Gastmeier P; Daschner FD
    J Hosp Infect; 2005 Aug; 60(4):348-52. PubMed ID: 15923060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of hospital-acquired bacteraemia in intensive care unit patients in a university hospital in Kuwait.
    Jamal WY; El-Din K; Rotimi VO; Chugh TD
    J Hosp Infect; 1999 Sep; 43(1):49-56. PubMed ID: 10462639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa in Swedish ICUs.
    Erlandsson M; Gill H; Nordlinder D; Giske CG; Jonas D; Nilsson LE; Walther S; Hanberger H
    Scand J Infect Dis; 2008; 40(6-7):487-94. PubMed ID: 18584536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of emergence of Pseudomonas aeruginosa resistance to beta-lactam antibiotics in intensive care units.
    Georges B; Conil JM; Dubouix A; Archambaud M; Bonnet E; Saivin S; Lauwers-Cancès V; Cristini C; Cougot P; Decun JF; Mathe O; Chabanon G; Marty N; Seguin T; Houin G
    Crit Care Med; 2006 Jun; 34(6):1636-41. PubMed ID: 16557152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiologic spectrum and susceptibility pattern of clinical isolates from the pediatric intensive care unit in a single medical center - 6 years' experience.
    Lee CY; Chen PY; Huang FL; Lin CF
    J Microbiol Immunol Infect; 2009 Apr; 42(2):160-5. PubMed ID: 19597649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.